The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ANGO | +66.99% | +9.67% | +1.86% | -6% |
| S&P | +14.5% | +93.32% | +14.09% | +497% |
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
Even 37 years after its founding, AngioDynamics still can't earn a profit.
AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $75.71M | 12.2% |
| Gross Profit | $39.20M | 14.8% |
| Gross Margin | 51.78% | 1.2% |
| Market Cap | $416.90M | 38.8% |
| Market Cap / Employee | $0.62M | 0.0% |
| Employees | 675 | -9.8% |
| Net Income | -$10.90M | 14.8% |
| EBITDA | -$1.88M | 2.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $38.76M | -29.5% |
| Accounts Receivable | $42.64M | 7.8% |
| Inventory | 62.3 | -3.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.73M | -50.6% |
| Short Term Debt | $1.77M | -8.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -11.48% | 50.2% |
| Return On Invested Capital | -26.22% | 3.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$17.47M | 15.5% |
| Operating Free Cash Flow | -$15.91M | 12.8% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.45 | 2.03 | 2.25 | 2.30 | 56.68% |
| Price to Sales | 0.99 | 1.34 | 1.43 | 1.40 | 35.59% |
| Price to Tangible Book Value | 2.35 | 3.34 | 3.64 | 3.69 | 57.02% |
| Enterprise Value to EBITDA | 130.74 | -1030.89 | 166.40 | -206.17 | 56.52% |
| Return on Equity | -76.4% | -20.5% | -17.5% | -17.1% | -78.03% |
| Total Debt | $4.91M | $4.40M | $3.95M | $3.50M | -35.47% |
ANGO earnings call for the period ending August 31, 2021.
ANGO earnings call for the period ending May 31, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
